Articles

Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies

Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN;Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN;Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN;Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
Stem Cell/Bone Marrow Transplantation Program, Dana-Farber Cancer Institute, Boston, MA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN;Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN;Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN;Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.193441